Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study

BACKGROUND: Prevalence of inflammatory bowel disease (IBD) is increasing in China. The EXPLORE study evaluated the incidence and indicators of suboptimal responses to first-line anti-tumor necrosis factor (TNF) in patients with ulcerative colitis (UC) or Crohn’s disease (CD). We present results for...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ji, Liu, Zhanju, Hu, Pinjin, Wen, Zhonghui, Cao, Qian, Zou, Xiaoping, Chen, Yan, Wang, Yingde, Zhong, Jie, Shen, Xizhong, Demuth, Dirk, Fadeeva, Olga, Xie, Li, Chen, Jun, Qian, Jiaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817491/
https://www.ncbi.nlm.nih.gov/pubmed/35120446
http://dx.doi.org/10.1186/s12876-021-02074-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817491/
https://www.ncbi.nlm.nih.gov/pubmed/35120446
http://dx.doi.org/10.1186/s12876-021-02074-z

Ejemplares similares